{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:52:08Z","timestamp":1792788728971,"version":"4.5.0"},"reference-count":21,"publisher":"Bentham Science Publishers Ltd.","issue":"4","funder":[{"DOI":"10.13039\/501100013795","name":"Startup Fund for Scientific Research Fujian Medical University","doi-asserted-by":"publisher","award":["2021QH1351"],"award-info":[{"award-number":["2021QH1351"]}],"id":[{"id":"10.13039\/501100013795","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fuzhou Health Young and Middle-aged Scientific Research Project","award":["2021-S-wq36"],"award-info":[{"award-number":["2021-S-wq36"]}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CGT"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Abnormal live function tests have been identified as independent risk factors\nfor ominous prognosis in patients with heart failure. However, most of the previous studies have\nfailed to determine the contribution of direct bilirubin (DBIL) and indirect bilirubin (IBIL) separately.\nHence, we aimed to explore whether DBIL or IBIL is correlated with the prognosis of heart failure\nwith preserved ejection fraction (HFpEF).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A total of 19837 patients were hospitalized for HFpEF between January 2012 and January\n2022 in Fuqing City Hospital affiliated with Fujian Medical University. The primary endpoint\nwas in-hospital all-cause mortality. Secondary endpoints included in-hospital cardiovascular mortality\nand 30-day re-admission for heart failure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Univariable analysis indicated that patients with elevated DBIL or IBIL were exposed to a\nhigher risk of mortality and re-admission. However, in multivariable models, both ln-transformed\nDBIL and TBIL, but not IBIL, were independent risk factors for in-hospital all-cause mortality\n[hazard ratio (HR)=1.796, 95% confidential interval (CI)=1.477-2.183, P\uff1c0.001; HR=1.854, 95%\nCI=1.461-2.352, P\uff1c0.001; HR=1.161, 95% CI=0.959-1.407, P=0.126] and in-hospital cardiovascular\nmortality (HR=1.831, 95% CI=1.345-2.492, P\uff1c0.001; HR=1.899, 95% CI=1.300-2.773,\nP=0.001; HR=1.145, 95% CI=0.841-1.561, P=0.389). Only DBIL remained independently associated\nwith 30-day readmission for heart failure (HR=1.361, 95% CI=1.036-1.787, P=0.027). Adding\nln-transformed DBIL to model 1 increased its discriminatory capacity (C-statistic: 0.851 to 0.869,\nrespectively), whereas adding ln-transformed IBIL yielded little increment (C-statistic: 0.851 to\n0.852, respectively).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>DBIL, but not IBIL, was associated with short-term ominous prognosis in patients\nwith HFpEF. Hence, DBIL may be the superior predictor for prognosis in HFpEF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0115665232273115240102043640","type":"journal-article","created":{"date-parts":[[2024,2,4]],"date-time":"2024-02-04T08:01:40Z","timestamp":1707033700000},"page":"321-330","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Direct Bilirubin, but not Indirect Bilirubin, is Associated with Short-term\nAdverse Events in HFpEF"],"prefix":"10.2174","volume":"24","author":[{"given":"Sunying","family":"Wang","sequence":"first","affiliation":[{"name":"Fuqing City Hospital Affiliated to Fujian Medical University, Fuqing, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics &amp; Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanghao","family":"Ma","sequence":"additional","affiliation":[{"name":"Ningde People's Hospital, Ningde, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Management, Fujian Yirong Information Technology Corporation, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manqing","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianwei","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fujian Provincial Hospital, Fuzhou, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyong","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Jinshan Branch of Fujian Provincial Hospital, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaijin","family":"Lin","sequence":"additional","affiliation":[{"name":"Fuqing City Hospital Affiliated to Fujian Medical University, Fuqing, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meihua","family":"Lin","sequence":"additional","affiliation":[{"name":"Fuqing City Hospital Affiliated to Fujian Medical University, Fuqing, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Lin","sequence":"additional","affiliation":[{"name":"Fuqing City Hospital Affiliated to Fujian Medical University, Fuqing, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Chen","sequence":"additional","affiliation":[{"name":"Fuqing City Hospital Affiliated to Fujian Medical University, Fuqing, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaowen","family":"Zheng","sequence":"additional","affiliation":[{"name":"Fuqing City Hospital Affiliated to Fujian Medical University, Fuqing, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuqing","family":"Sun","sequence":"additional","affiliation":[{"name":"Fuqing City Hospital Affiliated to Fujian Medical University, Fuqing, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski P.","year":"2016","unstructured":"Ponikowski P.; Voors A.A.; Anker S.D.; 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J  2016,37(27),2129-2200","journal-title":"Eur Heart J"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1056\/NEJMoa052256","volume":"355","author":"Owan T.E.","year":"2006","unstructured":"Owan T.E.; Hodge D.O.; Herges R.M.; Jacobsen S.J.; Roger V.L.; Redfield M.M.; Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med  2006,355(3),251-259","journal-title":"N Engl J Med"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1002\/ejhf.1853","volume":"22","author":"Suzuki K.","year":"2020","unstructured":"Suzuki K.; Claggett B.; Minamisawa M.; Liver function and prognosis, and influence of sacubitril\/valsartan in patients with heart failure with reduced ejection fraction. Eur J Heart Fail  2020,22(9),1662-1671","journal-title":"Eur J Heart Fail"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/ejhf.440","volume":"18","author":"Samsky M.D.","year":"2016","unstructured":"Samsky M.D.; Dunning A.; DeVore A.D.; Liver function tests in patients with acute heart failure and associated outcomes: Insights from ASCEND\u2010HF. Eur J Heart Fail  2016,18(4),424-432","journal-title":"Eur J Heart Fail"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/4857917","volume":"2016","author":"Yokoyama M.","year":"2016","unstructured":"Yokoyama M.; Watanabe T.; Otaki Y.; Associatowion of the aspartate aminotransferase to alanine aminotransferase ratio with bnp level and cardiovascular mortality in the general population: The yamagata study 10-year foll-Up. Dis Markers  2016,2016,1-9","journal-title":"Dis Markers"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1093\/eurjhf\/hfn031","volume":"11","author":"Allen L.A.","year":"2009","unstructured":"Allen L.A.; Felker G.M.; Pocock S.; Liver function abnormalities and outcome in patients with chronic heart failure: Data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Eur J Heart Fail  2009,11(2),170-177","journal-title":"Eur J Heart Fail"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"618816","DOI":"10.3389\/fcvm.2021.618816","volume":"8","author":"Liang W.","year":"2021","unstructured":"Liang W.; He X.; Wu D.; Prognostic implication of liver function tests in heart failure with preserved ejection fraction without chronic hepatic diseases: Insight from TOPCAT trial. Front Cardiovasc Med  2021,8,618816","journal-title":"Front Cardiovasc Med"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.amjcard.2019.11.006","volume":"125","author":"Prenner S.B.","year":"2020","unstructured":"Prenner S.B.; Kumar A.; Zhao L.; Effect of serum albumin levels in patients with heart failure with preserved ejection fraction (from the TOPCAT Trial). Am J Cardiol  2020,125(4),575-582","journal-title":"Am J Cardiol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1161\/CIRCULATIONAHA.115.020894","volume":"133","author":"Sundaram V.","year":"2016","unstructured":"Sundaram V.; Fang J.C.; Gastrointestinal and liver issues in heart failure. Circulation  2016,133(17),1696-1703","journal-title":"Circulation"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"197","DOI":"10.5152\/tjg.2015.0086","volume":"26","author":"\u00c7a\u011fl\u0131 K.","year":"2020","unstructured":"\u00c7a\u011fl\u0131 K.; Ba\u015far F.N.; Tok D.; Turak O.; Ba\u015far O.; How to interpret liver function tests in heart failure patients? Turk J Gastroenterol  2020,26(3),197-203","journal-title":"Turk J Gastroenterol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"650191","DOI":"10.3389\/fcvm.2021.650191","volume":"8","author":"Wang S.","year":"2021","unstructured":"Wang S.; Wang Y.; Luo M.; MELD-XI score is associated with short-term adverse events in patients with heart failure with preserved ejection. Front Cardiovasc Med  2021,8,650191","journal-title":"Front Cardiovasc Med"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"McDonagh T.A.","year":"2021","unstructured":"McDonagh T.A.; Metra M.; Adamo M.; 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J  2021,42(36),3599-3726","journal-title":"Eur Heart J"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.amjcard.2012.12.048","volume":"111","author":"Wu A.H.","year":"2013","unstructured":"Wu A.H.; Levy W.C.; Welch K.B.; Association between bilirubin and mode of death in severe systolic heart failure. Am J Cardiol  2013,111(8),1192-1197","journal-title":"Am J Cardiol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00380-020-01666-1","volume":"36","author":"Shiomura R.","year":"2021","unstructured":"Shiomura R.; Kobayashi N.; Shirakabe A.; Systolic blood pressure and cardiac mortality related to serum total bilirubin levels at admission in patients with acute heart failure. Heart Vessels  2021,36(1),69-75","journal-title":"Heart Vessels"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/0717-6287-47-7","volume":"47","author":"Zheng H.","year":"2014","unstructured":"Zheng H.; Li Y.; Xie N.; Association of serum total bilirubin levels with diastolic dysfunction in heart failure with preserved ejection fraction. Biol Res  2014,47(1),7","journal-title":"Biol Res"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.cardfail.2014.03.003","volume":"20","author":"van Deursen V.M.","year":"2014","unstructured":"van Deursen V.M.; Edwards C.; Cotter G.; Liver function, in-hospital, and post-discharge clinical outcome in patients with acute heart failure-results from the relaxin for the treatment of patients with acute heart failure study. J Card Fail  2014,20(6),407-413","journal-title":"J Card Fail"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1067146","DOI":"10.3389\/fgene.2023.1067146","volume":"14","author":"Guan B.","year":"2023","unstructured":"Guan B.; Yang M.; Shen X.; Genetically determined serum bilirubin level and the risk of heart failure: A mendelian randomization study. Front Genet  2023,14,1067146","journal-title":"Front Genet"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1016\/j.amjcard.2017.03.033","volume":"119","author":"Okada A.","year":"2017","unstructured":"Okada A.; Sugano Y.; Nagai T.; Usefulness of the direct and\/or total bilirubin to predict adverse outcomes in patients with acute decompensated heart failure. Am J Cardiol  2017,119(12),2035-2041","journal-title":"Am J Cardiol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s11739-019-02033-3","volume":"14","author":"Durante-Mangoni E.","year":"2019","unstructured":"Durante-Mangoni E.; Parrella A.; Pafundi P.C.; Liver histopathological findings in advanced heart failure: A reappraisal of cardiac cirrhosis concept. Intern Emerg Med  2019,14(6),931-940","journal-title":"Intern Emerg Med"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ijcard.2011.07.056","volume":"161","author":"Kato T.","year":"2012","unstructured":"Kato T.; Niizuma S.; Inuzuka Y.; Analysis of liver metabolism in a rat model of heart failure. Int J Cardiol  2012,161(3),130-136","journal-title":"Int J Cardiol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/ehf2.12222","volume":"5","author":"Yoshihisa A.","year":"2018","unstructured":"Yoshihisa A.; Sato Y.; Yokokawa T.; Liver fibrosis score predicts mortality in heart failure patients with preserved ejection fraction. ESC Heart Fail  2018,5(2),262-270","journal-title":"ESC Heart Fail"}],"container-title":["Current Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115665232273115240102043640","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/225707\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115665232273115240102043640","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T09:14:50Z","timestamp":1715937290000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/225707\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115665232273115240102043640","relation":{},"ISSN":["1566-5232"],"issn-type":[{"value":"1566-5232","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-08-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}